An association between a novel pediatric hyperinflammatory condition and SARS-CoV-2
was recently published and termed pediatric inflammatory multisystem syndrome, temporally …

Abstract Information regarding the novel coronavirus disease (COVID‐19) in pediatric
oncology is limited. We conducted a systematic review of the available published literature …

The ongoing coronavirus disease 2019 (COVID-19) pandemic has left patients with current
or past history of cancer facing disparate consequences at every stage of the cancer …

Since the emergence of the SARS-CoV-2 infection, many recommendations have been
made. However, the very specific nature of acute lymphoblastic leukemias and their …

SARS-CoV-2 pandemic affected fewer children and adolescents with lower morbidity and
mortality rates than those reported for adults. This review focused on the clinical course, risk …

A cytokine storm is an uncontrolled, excessive immune response that contributes to the
pathogenesis of coronavirus disease 2019 (COVID‑19). Viral infections lead to the loss of …

With the emergence of the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2)
virus, the pandemic has resulted in a severe respiratory disease known as COVID-19. Data …

Background: SARS-CoV-2 infection tends to be lethal to the elderly population. However,
sometimes children are also involved. Case Presentation: We present the case of a female …

The Multisystem Inflammatory Syndrome in Children (MIS-C) is a postinfectious syndrome
associated with coronavirus disease 2019 (COVID-19) disease in children. The aim of this …

Background: Blood cancer is the most common type of cancer and the leading cause of
death by disease past infancy among children. Children with blood cancer are vulnerable …